Novel therapeutic strategies in the treatment of triple-negative breast cancer

Novel therapeutic strategies in the treatment of triple-negative breast cancer

Triple-negative breast cancer (TNBC) is a heterogeneous subtype of breast cancer that is defined by negative estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) status. Treating patients with TNBC remains clinically challenging, as patients are not...

Full description

Bibliographic Details
Main Authors: Karima Oualla, Heba M. El-Zawahry, Banu Arun, James M. Reuben, Wendy A. Woodward, Heba Gamal El-Din, Bora Lim, Nawfel Mellas, Naoto T. Ueno, Tamer M. Fouad
Format: Article
Language:English
Published: SAGE Publishing 2017-07-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758834017711380

Internet

https://doi.org/10.1177/1758834017711380

Similar Items